Position in NVNO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$55,777
+$3,010 QoQ
Shares Held
5,208
-0.0% QoQ
Ownership
0.763%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 17 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVNO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,248,837,970 across 100 Medical Devices names. NVNO ranks #75 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
17,260,943 | $5,434,435,284 | |
| 2 | MDT |
Medtronic plc
|
27,784,471 | $2,173,579,157 | |
| 3 | EW |
Edwards Lifesciences Corp
|
22,783,175 | $2,060,966,003 | |
| 4 | ABT |
Abbott Laboratories
|
15,095,898 | $1,369,801,775 | |
| 5 | BSX |
Boston Scientific Corp
|
23,907,838 | $1,020,386,517 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
10,329,164 | $661,169,779 | |
| 7 | PEN |
Penumbra Inc
|
1,071,454 | $338,311,597 | |
| 8 | DXCM |
Dexcom Inc
|
3,325,095 | $223,945,140 |
All Filings in NVNO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,777 | 5,208 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $52,767 | 5,209 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $58,519 | 182,303 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $165,183 | 182,322 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $727,377 | 182,300 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $510,780 | 194,213 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $815,523 | 270,041 | Shares | Defined | 2025-02-12 | |
| 2023-09-30 | $59 | 11 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||